EU approves AstraZeneca lung cancer immunotherapy
AstraZeneca’s immunotherapy drug Imfinzi was approved in Europe for use in lung cancer patients with inoperable disease that had advanced locally but not spread widely around the body.
Lilly Migraine Medicine Emgality Receives European Panel Approval Recommendation
Merck KGaA, Pfizer's Immuno-Drug Bavencio Shown To Alleviate Kidney Cancer
Teva Wins Reversal Of U.S. Jury's $235 Million GSK Drug Patent Verdict
Sanofi Pledges To Keep Up Restructuring Efforts
EU Approves Fifth Copy Of AbbVie's Humira
Allergan and Sosei Halt Alzheimer’s Trial Over Safety Concerns
AstraZeneca Plots China Robot Offensive To Counter Price Cuts
J&J Tops Drucker Institute’s Management Top 250
CVS-Aetna Deal To Change How Big Employers Buy Health Benefits
FDA Panel Votes Against Approval Of GSK's Lung Disease Drug
Endo International Places Second Temporary Hold on Compounding Lawsuit
Otsuka, Lundbeck To Start Third Phase 3 Trial To Evaluate Brexpiprazole In Treatment Of Agitation In Patients With Alzheimer's Disease
California Insurance Regulator Sues AbbVie Alleging Humira Kickbacks
Amgen’s Aimovig Starts Strong, Multiple Myeloma Drug Wows At Conference
Eli Lilly Seeking Cancer Deals To Bolster Pipeline
Amicus Therapeutics Buys Celenex
Bayer Hemophilia Treatment Jivi Wins Thumbs-Up From EU Panel
Former Valeant, Philidor Executives Found Guilty In Kickback Scheme
Gilead CEO To Step Down At End Of 2018
FDA Approves Subcutaneous Formulation of Actemra for Rare Form of Juvenile Arthritis
Investors Turn Wary On Biogen/Eisai Alzheimer's Drug Results
Takeda Lung Cancer Drug Alunbrig Gets European Panel Nod
FDA Approves New Indication For Gilotrif In EGFR Mutation-Positive NSCLC
Xtandi Delays Prostate Cancer Spread In Early-Stage Disease
Alexion Submits Application for U.S. Priority Review and Approval of ALXN1210 as Treatment for PNH
Shire’s Sales Up Ahead Of Takeda Acquisition
Merck's Keytruda Succeeds In Late-Stage Lung Cancer Study
UK Rejects Adult Novartis CAR-T Therapy, After 'Yes' In Kids
Bristol-Myers Squibb Experimental Plaque Psoriasis Drug Shows Promise In Mid-Stage Trial
Novo Nordisk lays off 400 staff in research & development unit
Ad Right Top
Latest News
Boston Scientific drug-coated stent gets FDA approval
The U.S. Food and Drug Administration approved Boston Scientific Corp.’s drug-coated stent Eluvia to treat narrowed arteries in the leg.
AstraZeneca’s Diabetes Drug Farxiga Decreases Risk of Cardiovascular Disease
AstraZeneca announced positive results from the company's Phase III DECLARE-TIMI 58 cardiovascular outcomes clinical trial of Farxiga (dapagliflozin).
Most Commented
Sorry. No data so far.
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!